Cite

HARVARD Citation

    Chen, Y. et al. (2019). S‐1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial. Oncologist. pp. 591-e165. [Online]. 
  
Back to record